Targeting STING in cancer: Challenges and emerging opportunities
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-11 · 1878 (6) · 188983
DOI: 10.1016/j.bbcan.2023.188983 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-11. Verfasst von Kexin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China; Department of Immunology, Jiangsu Key Laboratory…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 192 Literaturangaben.
Abstract (Originalsprache)
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway is a key pathway through which the host regulates immune responses by recognizing cytoplasmic double-stranded DNA of abnormal origin, and it plays an important role in tumor growth as well as metastasis, with relevant molecular details constantly being explored and updated. The significant immunomodulatory effects make STING an attractive target for cancer immunotherapy, and STING agonists have been receiving great attention for their development and clinical translation. Despite exciting results in preclinical work, the application of STING agonists to cancer therapy remains challenging due to their poor pharmacokinetic and physicochemical properties, as well as toxic side effects they produce. Here, we summarize the dichotomous role of cGAS-STING in cancer and discuss the limitations of cancer immunotherapy based on STING activation as well as feasible strategies to overcome them to achieve tumor regression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China; Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenj…
- Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
- Department of Immunology, Jiangsu Key Laboratory of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China; Department of Laboratory Medicine, the Affiliated People's Hospital, Jiangsu University,…
- Department of Laboratory Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China. Electronic address: xujuan20230419@njmu.edu.cn.
- Department of General Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China. Electronic address: jsyinkai@163.com.
Zitieren
APA
Zhao, K., Huang, J., Zhao, Y., Wang, S., Xu, J., & Yin, K. (2023). Targeting STING in cancer: Challenges and emerging opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(6), 188983. https://doi.org/10.1016/j.bbcan.2023.188983
Vancouver
Zhao K, Huang J, Zhao Y, Wang S, Xu J, Yin K. Targeting STING in cancer: Challenges and emerging opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(6):188983. doi:10.1016/j.bbcan.2023.188983
BibTeX
@article{Zhao2023,
author = {Zhao, Kexin and Huang, Jiaojiao and Zhao, Yue and Wang, Shengjun and Xu, Juan and Yin, Kai},
title = {Targeting STING in cancer: Challenges and emerging opportunities},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {6},
pages = {188983},
doi = {10.1016/j.bbcan.2023.188983}
}
EUVIMED